Ampersand closes $1.5bn healthcare fund at hard cap
Ampersand Capital Partners, a middle-market private equity firm specialised in growth-oriented healthcare investments, has announced the final closure of its twelfth primary fund, Ampersand 2026 Limited Partnership, at its hard cap of $1.bn. The oversubscribed vehicle, known as AMP-26, was wrapped up in a single close less than five months after its initial launch. It received substantial backing from a…